Accepted answer
15 ÷ 2 = 7.5 mg/mL. Concentration is vial content divided by diluent volume, so 15 mg of peptide in 2 mL of phosphate-buffered diluent gives 7.5 mg/mL. On a U-100 barrel one unit is 0.01 mL, so one unit of this solution carries 0.075 mg — 75 µg. That is the number to write on the label, because you will not reconstruct it from memory at an awkward moment.
Add the diluent down the vial wall rather than directly onto the cake. Peptides are surface-active and shear at an air–liquid interface, so a jet of water into a lyophilised puck generates foam, and foam is aggregated protein at the interface, not just air.
On re-freezing something that thawed in transit: if it arrived as a lyophilised solid that warmed but never got wet, re-freezing costs you nothing except the thermal cycle.
Reading a lyophilised cake
| Appearance | Interpretation | Action |
|---|
| Intact opaque puck, proud of base | Cycle ran correctly | Proceed |
| Slumped to one side | Shipped before fully dry, or vibration | Usually usable; note it |
| Glassy translucent film | Collapse above glass transition | Test before use |
| Melt-back ring at stopper | Thermal excursion in transit | Test before use |
| No visible cake at all | Very low fill, or nothing there | Weigh it; query the supplier |
In practice, photograph the vial against a matte black card with a single point light source off to one side, not with a flash from the front.
Published data on syringe dead space in the context of injection-equipment programmes quantifies low-dead-space designs as retaining under 2 µL against 35 µL or more.
The caveat is that this is not a recommendation to administer anything. Research-use-only material is not approved for human use.
None of this is exotic. It is just the difference between doing it deliberately and doing it approximately.
edited 8 Feb 2026 by laminar_bench — tightened the wording; no substantive change